This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated VANGL2 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-VANGL2 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~59.7 kDa | |
| Gel | 12–15% (standard starting point) | |
| Negative control | Suggested KO / knockdown lysate |
| PTM | — | |
| Caveat | Membrane extraction controls | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 1 isoform(s) |
The A04309 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | extracts of various cell lines, (catalog A04309) |
| Gel % | 12–15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Standard semi-dry transfer; verify efficiency (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | Blocking buffer: 3% nonfat dry milk in TBST (catalog A04309) |
| Primary antibody | A04309 · 1:1000 (catalog A04309) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Goat Anti-Rabbit IgG, 1:10000 (catalog A04309) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL (catalog A04309) |
VANGL2 has a predicted monomer mass of 59.7 kDa; dimerization may affect bands, but no empirical migration or size shift is established.
| Band near 59.7 kDa | consistent with the predicted VANGL2 monomer; confirm its identity with controls |
| Band near 119 kDa | could reflect a VANGL2 homodimer if it remains intact during electrophoresis |
| Additional higher band of uncertain size | could reflect a VANGL2–VANGL1 heterodimer if the complex persists |
| Faint or absent band in lysate | membrane VANGL2 may be poorly recovered during extraction |
| Predicted monomer mass | 59.7 kDa for the full-length protein; actual migration is unverified |
| VANGL2 homodimer | could appear near twice the monomer mass if it survives electrophoresis |
| VANGL1 heterodimer | could produce a higher band if intact; its apparent mass is unknown |
| Multi-pass membrane topology | may affect apparent migration, but no size shift is established |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | membrane VANGL2 may be poorly extracted | check membrane fraction recovery and use a positive control |
| Band higher than expected | a VANGL2 homodimer or VANGL1 heterodimer may persist | compare reducing and denaturing conditions and verify band identity |
| Band lower than expected | band identity or sample integrity is uncertain; no cleavage feature is supplied | check sample integrity and confirm with an independent antibody |
| Multiple bands | monomer and persistent dimers are possible, but band identities are unproven | compare denaturing conditions and use VANGL2-specific controls |
| Weak or no signal | insufficient recovery of this multi-pass membrane protein is possible | check solubilization and include a positive control |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No high/medium HPA tissues identified in the supplied evidence. | ||||
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No lower-expression tissue rows available in the supplied evidence. | ||||
Deeper troubleshooting and optimisation questions for VANGL2, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
The catalog reports A04309, an anti-VANGL2 antibody with reported Human and Mouse reactivity. Its Western blot image shows extracts from various cell lines tested at 1:1000 dilution; the caption does not identify those cell lines.
Which to pick: A04309 is the only listed option. It has a Western blot image using 25 µg of cell-line extract per lane and a 1:1000 primary dilution. Check whether its reported Human or Mouse reactivity fits your sample.